Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds

Posted November 11, 2024

New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.

Health News is provided as a service to Rush Memorial Hospital Pharmacy site users by HealthDay. Rush Memorial Hospital Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Get Healthy!

Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds

Copyright © 2024 HealthDay All Rights Reserved.

Tags

Patient Resources

Get Healthy!

Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds

Copyright © 2024 HealthDay All Rights Reserved.

Share

Tags